Nephros (NEPH) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.12% |
| Dec 31, 2025 | -5.92% |
| Sep 30, 2025 | -2.77% |
| Jun 30, 2025 | -5.96% |
| Mar 31, 2025 | -8.43% |
| Dec 31, 2024 | -0.73% |
| Sep 30, 2024 | -2.11% |
| Jun 30, 2024 | -1.57% |
| Mar 31, 2024 | 2.40% |
| Dec 31, 2023 | 2.35% |
| Sep 30, 2023 | 3.03% |
| Jun 30, 2023 | 8.70% |
| Mar 31, 2023 | 18.73% |
| Dec 31, 2022 | 17.16% |
| Sep 30, 2022 | 32.04% |
| Jun 30, 2022 | 39.40% |
| Mar 31, 2022 | 36.48% |
| Dec 31, 2021 | 45.81% |
| Sep 30, 2021 | 42.71% |
| Jun 30, 2021 | 35.12% |
| Mar 31, 2021 | 39.24% |
| Dec 31, 2020 | 36.06% |
| Sep 30, 2020 | 28.77% |
| Jun 30, 2020 | 37.47% |
| Mar 31, 2020 | 47.48% |
| Dec 31, 2019 | 28.12% |
| Sep 30, 2019 | 30.06% |
| Jun 30, 2019 | 38.56% |
| Mar 31, 2019 | 27.08% |
| Dec 31, 2018 | 29.59% |
| Sep 30, 2018 | 29.76% |
| Jun 30, 2018 | 18.89% |
| Mar 31, 2018 | 11.10% |
| Dec 31, 2017 | 7.15% |
| Sep 30, 2017 | -6.52% |
| Jun 30, 2017 | -8.16% |
| Mar 31, 2017 | -1.85% |
| Dec 31, 2016 | -7.68% |
| Sep 30, 2016 | 0.85% |
| Jun 30, 2016 | 7.41% |
| Dec 31, 2015 | 20.08% |